Monovisc is an orthopaedic injection and a leading choice for healthcare providers and aesthetic practitioners who seek an effective solution for joint pain relief.
Available from reputable suppliers like Nu Derma Supply, Monovisc is designed for those seeking optimal results in patient care.
Medical professionals can buy Monovisc injections online from authorised sources to ensure authenticity and efficacy, making it a trusted product in the field of orthopaedics and joint care.
Monovisc is a leading brand in osteoarthritis treatment, renowned for its innovative approach to pain management.
Developed by Anika Therapeutics, Monovisc offers a single-injection solution that utilises hyaluronic acid to restore joint lubrication and alleviate discomfort.
Trusted by orthopaedic specialists, Monovisc has become synonymous with quality and efficacy in joint health therapy.
Monovisc is a single orthopaedic injection treatment based on hyaluronic acid and specifically designed to relieve pain in patients with osteoarthritis of the knee.
It works by supplementing the synovial fluid in the joint, restoring its natural lubrication and cushioning properties. This helps reduce pain, improve mobility, and slow down the progression of osteoarthritis.
Monovisc is unique because it provides relief with just one injection, unlike other hyaluronic acid products that require a series of injections.
The main ingredient in Monovisc is cross-linked hyaluronic acid (88 mg), which mimics the natural substance found in healthy joints. This cross-linking technology enhances the durability of the product, allowing it to provide long-lasting relief.
Explore the Nu Derma Supply catalogue to buy Monovisc online from a trusted distributor that guarantees the highest quality and product integrity.
Monovisc is primarily used to alleviate pain and discomfort in osteoarthritis patients. It can be injected into the following areas:
Monovisc is manufactured by Anika Therapeutics, Inc., a biotechnology company based in Massachusetts, USA.
Established in 1983, Anika Therapeutics has become a global leader in the development, manufacturing, and commercialisation of therapeutic products for tissue protection, healing, and repair.
Monovisc contains key components that make it safe and efficient in knee pain relief, including:
Yes, Monovisc is a hyaluronic acid-based product that provides sustained joint lubrication and pain relief.
The hyaluronic acid in Monovisc is cross-linked, making it more durable and longer-lasting than regular, non-cross-linked hyaluronic acid.
Monovisc must be administered by a licensed healthcare professional with training and experience in joint injections. Orthopaedic surgeons, rheumatologists, and general practitioners specialising in musculoskeletal conditions are commonly qualified to administer Monovisc.
While registered nurses with specialised training may also perform the injections under physician supervision, the procedure should always be conducted in a clinical setting to ensure safety.
Monovisc is administered as an intra-articular injection directly into the affected joint. The procedure is as follows:
Monovisc is available in a 4 mL syringe containing 88 mg of cross-linked hyaluronic acid. It is a single-dose treatment, designed to provide relief from osteoarthritis pain with just one injection.
Monovisc offers several key benefits for osteoarthritis patients:
The effects of Monovisc can last up to six months, depending on the severity of osteoarthritis and the patient’s individual response to treatment. Some patients may experience relief for a shorter or longer period.
To ensure optimal results from Monovisc injections, patients should follow these guidelines:
Before treatment
After treatment
Many patients report significant pain relief within a few weeks of the injection, with improved mobility and joint function.
Medical professionals often highlight the convenience of the single-dose injection, which reduces the need for multiple appointments and offers sustained relief.
Some reviews also mention that Monovisc helps patients delay more invasive procedures, such as joint replacement surgery, by providing effective pain management.
Monovisc generally has a good safety profile, but some patients may experience side effects, including:
Certain patients may not be candidates for Monovisc treatment. The following contraindications should be considered:
Orthopaedic surgeons, rheumatologists, and other qualified healthcare providers can buy Monovisc from authorised and trusted suppliers like Nu Derma Supply to ensure product authenticity and patient safety.
In the UK, Monovisc injections typically cost between £250 and £350 per 4 mL syringe, depending on the supplier and any promotions available.
In the Philippines, Monovisc is priced between PHP 18,000 and PHP 25,000 for a single 4 mL syringe, depending on the clinic and availability.
1. Is Monovisc injection a steroid?
No, Monovisc is not a steroid. It is a hyaluronic acid-based product that mimics the natural substance found in joints to provide lubrication and pain relief.
2. How does Monovisc work?
Monovisc works by supplementing the synovial fluid in the joint, improving lubrication and cushioning. This reduces pain, improves mobility, and helps protect the joint from further wear and tear.
3. How long does it take for Monovisc to start working?
Many patients start to notice relief within one to two weeks after the injection, with full benefits typically felt after three to four weeks.
4. Is Monovisc a one-time injection?
Yes, Monovisc is designed as a single injection treatment that provides relief for up to six months, although some patients may require additional injections later.
5. What is the difference between Monovisc and Durolane?
Both Monovisc and Durolane are hyaluronic acid-based injections, but Monovisc is administered as a single 4 mL injection, while Durolane is available in different formulations and is used more broadly for various joints.
6. Is Synvisc better than Monovisc?
Both Synvisc and Monovisc are effective treatments for osteoarthritis. However, Synvisc typically requires multiple injections, while Monovisc provides relief with just one injection. The choice depends on patient preference and the recommendation of the healthcare provider.
Join our newsletter to receive latest news and offers
Medicle MD Ltd
Reg. Number: 14317237
Address: 27 Old Gloucester Street,
WC1N 3AX London,
United Kingdom